Corcept Therapeutics To Pay $14M On Proposed Settlement Of Purported Securities Class Action
Corcept has reached a preliminary settlement of all claims in the purported securities class action against Corcept and certain of its executive officers captioned Melucci v. Corcept Therapeutics Incorporated,